Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 397

1.

Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial.

Kansal A, Huang Z, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FG, Katona B, Mahaffey KW, Norgren L, Hiatt WR, Patel MR, Jones WS.

Circ Cardiovasc Interv. 2019 Oct;12(10):e008069. doi: 10.1161/CIRCINTERVENTIONS.119.008069. Epub 2019 Oct 4.

PMID:
31581789
2.

IgM in human immunity to Plasmodium falciparum malaria.

Boyle MJ, Chan JA, Handayuni I, Reiling L, Feng G, Hilton A, Kurtovic L, Oyong D, Piera KA, Barber BE, William T, Eisen DP, Minigo G, Langer C, Drew DR, de Labastida Rivera F, Amante FH, Williams TN, Kinyanjui S, Marsh K, Doolan DL, Engwerda C, Fowkes FJI, Grigg MJ, Mueller I, McCarthy JS, Anstey NM, Beeson JG.

Sci Adv. 2019 Sep 25;5(9):eaax4489. doi: 10.1126/sciadv.aax4489. eCollection 2019 Sep.

3.

Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.

Oyong DA, Wilson DW, Barber BE, William T, Jiang J, Galinski MR, Fowkes FJI, Grigg MJ, Beeson JG, Anstey NM, Boyle MJ.

J Infect Dis. 2019 Nov 6;220(12):1950-1961. doi: 10.1093/infdis/jiz407.

PMID:
31419296
4.

The impact of community-delivered models of malaria control and elimination: a systematic review.

Win Han Oo, Gold L, Moore K, Agius PA, Fowkes FJI.

Malar J. 2019 Aug 6;18(1):269. doi: 10.1186/s12936-019-2900-1.

5.
6.

Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.

Hopley CW, Kavanagh S, Patel MR, Ostrom C, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Jones WS, Katona BG, Mahaffey KW, Norgren L, Rockhold FW, Hiatt WR.

Vasc Med. 2019 Oct;24(5):422-430. doi: 10.1177/1358863X19864172. Epub 2019 Jul 24.

PMID:
31339474
7.

Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.

Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, Rudan I.

Lancet Glob Health. 2019 Aug;7(8):e1020-e1030. doi: 10.1016/S2214-109X(19)30255-4.

8.

Acute Limb Ischemia in Peripheral Artery Disease.

Hess CN, Huang Z, Patel MR, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Held P, Jones WS, Katona B, Mahaffey KW, Norgren L, Rockhold FW, Hiatt WR.

Circulation. 2019 Aug 13;140(7):556-565. doi: 10.1161/CIRCULATIONAHA.119.039773. Epub 2019 Jun 26.

PMID:
31238713
9.

Ozonide Antimalarial Activity in the Context of Artemisinin-Resistant Malaria.

Giannangelo C, Fowkes FJI, Simpson JA, Charman SA, Creek DJ.

Trends Parasitol. 2019 Jul;35(7):529-543. doi: 10.1016/j.pt.2019.05.002. Epub 2019 Jun 5. Review.

10.

Stroke in Patients With Peripheral Artery Disease.

Kolls BJ, Sapp S, Rockhold FW, Jordan JD, Dombrowski KE, Fowkes FGR, Mahaffey KW, Berger JS, Katona BG, Blomster JI, Norgren L, Abramson BL, Leiva-Pons JL, Prieto JC, Sokurenko G, Hiatt WR, Jones WS, Patel MR.

Stroke. 2019 Jun;50(6):1356-1363. doi: 10.1161/STROKEAHA.118.023534. Epub 2019 May 16.

PMID:
31092165
11.

Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.

O'Flaherty K, Ataíde R, Zaloumis SG, Ashley EA, Powell R, Feng G, Reiling L, Dondorp AM, Day NP, Dhorda M, Fairhurst RM, Lim P, Amaratunga C, Pukrittayakamee S, Hien TT, Htut Y, Mayxay M, Faiz MA, Beeson JG, Nosten F, Simpson JA, White NJ, Fowkes FJI.

J Infect Dis. 2019 Aug 30;220(7):1178-1187. doi: 10.1093/infdis/jiz247.

12.

Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure.

Kurtovic L, Agius PA, Feng G, Drew DR, Ubillos I, Sacarlal J, Aponte JJ, Fowkes FJI, Dobaño C, Beeson JG.

BMC Med. 2019 Feb 25;17(1):45. doi: 10.1186/s12916-019-1277-x.

13.

Targets of complement-fixing antibodies in protective immunity against malaria in children.

Reiling L, Boyle MJ, White MT, Wilson DW, Feng G, Weaver R, Opi DH, Persson KEM, Richards JS, Siba PM, Fowkes FJI, Takashima E, Tsuboi T, Mueller I, Beeson JG.

Nat Commun. 2019 Feb 5;10(1):610. doi: 10.1038/s41467-019-08528-z.

14.

Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.

Gutierrez JA, Mulder H, Jones WS, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Held P, Katona BG, Mahaffey KW, Norgren L, Hiatt WR, Patel MR.

JAMA Netw Open. 2018 Nov 2;1(7):e185239. doi: 10.1001/jamanetworkopen.2018.5239.

15.

Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.

Low Wang CC, Blomster JI, Heizer G, Berger JS, Baumgartner I, Fowkes FGR, Held P, Katona BG, Norgren L, Jones WS, Lopes RD, Olin JW, Rockhold FW, Mahaffey KW, Patel MR, Hiatt WR; EUCLID Trial Executive Committee and Investigators.

J Am Coll Cardiol. 2018 Dec 25;72(25):3274-3284. doi: 10.1016/j.jacc.2018.09.078. Erratum in: J Am Coll Cardiol. 2019 Jul 16;74(2):264-269.

PMID:
30573030
16.

Effectiveness of repellent delivered through village health volunteers on malaria incidence in villages in South-East Myanmar: a stepped-wedge cluster-randomised controlled trial protocol.

Win Han Oo, Cutts JC, Agius PA, Kyaw Zayar Aung, Poe Poe Aung, Aung Thi, Nyi Nyi Zaw, Htin Kyaw Thu, Wai Yan Min Htay, Ataide R, O'Flaherty K, Ai Pao Yawn, Aung Paing Soe, Beeson JG, Crabb B, Pasricha N, Fowkes FJI.

BMC Infect Dis. 2018 Dec 14;18(1):663. doi: 10.1186/s12879-018-3566-y.

17.

Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.

Olivier CB, Mulder H, Hiatt WR, Jones WS, Fowkes FGR, Rockhold FW, Berger JS, Baumgartner I, Held P, Katona BG, Norgren L, Blomster J, Patel MR, Mahaffey KW.

JAMA Cardiol. 2019 Jan 1;4(1):7-15. doi: 10.1001/jamacardio.2018.4171.

PMID:
30540355
18.

Antibody Targets on the Surface of Plasmodium falciparum-Infected Erythrocytes That Are Associated With Immunity to Severe Malaria in Young Children.

Chan JA, Boyle MJ, Moore KA, Reiling L, Lin Z, Hasang W, Avril M, Manning L, Mueller I, Laman M, Davis T, Smith JD, Rogerson SJ, Simpson JA, Fowkes FJI, Beeson JG.

J Infect Dis. 2019 Feb 15;219(5):819-828. doi: 10.1093/infdis/jiy580.

PMID:
30365004
19.

Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial.

Baumgartner I, Norgren L, Fowkes FGR, Mulder H, Patel MR, Berger JS, Jones WS, Rockhold FW, Katona BG, Mahaffey K, Hiatt WR; Executive Committee and Investigators of the EUCLID Trial.

J Am Coll Cardiol. 2018 Oct 2;72(14):1563-1572. doi: 10.1016/j.jacc.2018.07.046.

20.

In Silico Investigation of the Decline in Clinical Efficacy of Artemisinin Combination Therapies Due to Increasing Artemisinin and Partner Drug Resistance.

Zaloumis SG, Cao P, Dini S, Davenport MP, Cromer D, Khoury DS, Fowkes FJI, McCaw JM, Simpson JA.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01292-18. doi: 10.1128/AAC.01292-18. Print 2018 Dec.

21.

Iron deficiency during pregnancy is associated with a reduced risk of adverse birth outcomes in a malaria-endemic area in a longitudinal cohort study.

Fowkes FJI, Moore KA, Opi DH, Simpson JA, Langham F, Stanisic DI, Ura A, King CL, Siba PM, Mueller I, Rogerson SJ, Beeson JG.

BMC Med. 2018 Sep 20;16(1):156. doi: 10.1186/s12916-018-1146-z.

22.

Peripheral Artery Disease.

Sampson UKA, Fowkes FGR, Naidoo NG, Criqui MH.

In: Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y, Nugent R, editors. Cardiovascular, Respiratory, and Related Disorders. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 17. Chapter 14.

23.

Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.

Dini S, Zaloumis S, Cao P, Price RN, Fowkes FJI, van der Pluijm RW, McCaw JM, Simpson JA.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01068-18. doi: 10.1128/AAC.01068-18. Print 2018 Nov.

24.

Implications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical model.

Scott N, Ataide R, Wilson DP, Hellard M, Price RN, Simpson JA, Fowkes FJI.

Malar J. 2018 Aug 2;17(1):279. doi: 10.1186/s12936-018-2418-y.

25.

Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.

Berger JS, Abramson BL, Lopes RD, Heizer G, Rockhold FW, Baumgartner I, Fowkes FGR, Held P, Katona BG, Norgren L, Jones WS, Millegård M, Blomster J, Reist C, Hiatt WR, Patel MR, Mahaffey KW.

Vasc Med. 2018 Dec;23(6):523-530. doi: 10.1177/1358863X18775594. Epub 2018 Jul 11.

PMID:
29992857
26.

International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.

Mok Y, Ballew SH, Bash LD, Bhatt DL, Boden WE, Bonaca MP, Carrero JJ, Coresh J, D'Agostino RB Sr, Elley CR, Fowkes FGR, Jee SH, Kovesdy CP, Mahaffey KW, Nadkarni G, Peterson ED, Sang Y, Matsushita K.

J Am Heart Assoc. 2018 Jul 7;7(14). pii: e008426. doi: 10.1161/JAHA.117.008426.

27.

Anopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.

Ya-Umphan P, Cerqueira D, Cottrell G, Parker DM, Fowkes FJI, Nosten F, Corbel V.

Am J Trop Med Hyg. 2018 Aug;99(2):350-356. doi: 10.4269/ajtmh.18-0081. Epub 2018 May 31.

28.

Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children.

Kurtovic L, Behet MC, Feng G, Reiling L, Chelimo K, Dent AE, Mueller I, Kazura JW, Sauerwein RW, Fowkes FJI, Beeson JG.

BMC Med. 2018 Apr 30;16(1):61. doi: 10.1186/s12916-018-1054-2.

29.

Predictors of Bleeding in Patients with Symptomatic Peripheral Artery Disease: A Cohort Study Using The Health Improvement Network in the United Kingdom.

Cea Soriano L, Fowkes FGR, Allum AM, Johansson S, García Rodriguez LA.

Thromb Haemost. 2018 Jun;118(6):1101-1112. doi: 10.1055/s-0038-1646923. Epub 2018 Apr 27.

PMID:
29702713
30.

External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.

Williams BA, Chagin KM, Bash LD, Boden WE, Duval S, Fowkes FGR, Mahaffey KW, Patel MD, D'Agostino RB, Peterson ED, Kattan MW, Bhatt DL, Bonaca MP.

Atherosclerosis. 2018 May;272:80-86. doi: 10.1016/j.atherosclerosis.2018.03.026. Epub 2018 Mar 16.

PMID:
29579671
31.

Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.

Cea-Soriano L, Fowkes FGR, Johansson S, Allum AM, García Rodriguez LA.

BMJ Open. 2018 Jan 21;8(1):e018184. doi: 10.1136/bmjopen-2017-018184.

32.

Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.

Norgren L, Patel MR, Hiatt WR, Wojdyla DM, Fowkes FGR, Baumgartner I, Mahaffey KW, Berger JS, Jones WS, Katona BG, Held P, Blomster JI, Rockhold FW, Björck M; EUCLID Steering Committee and Investigators.

Eur J Vasc Endovasc Surg. 2018 Jan;55(1):109-117. doi: 10.1016/j.ejvs.2017.11.006. Epub 2017 Dec 20.

33.

Cardiovascular outcomes for patients with symptomatic peripheral artery disease: A cohort study in The Health Improvement Network (THIN) in the UK.

Cea Soriano L, Fowkes FGR, Johansson S, Allum AM, García Rodriguez LA.

Eur J Prev Cardiol. 2017 Dec;24(18):1927-1937. doi: 10.1177/2047487317736824. Epub 2017 Oct 20.

PMID:
29053020
34.

P. falciparum infection and maternofetal antibody transfer in malaria-endemic settings of varying transmission.

McLean ARD, Stanisic D, McGready R, Chotivanich K, Clapham C, Baiwog F, Pimanpanarak M, Siba P, Mueller I, King CL, Nosten F, Beeson JG, Rogerson S, Simpson JA, Fowkes FJI.

PLoS One. 2017 Oct 13;12(10):e0186577. doi: 10.1371/journal.pone.0186577. eCollection 2017.

35.

A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.

Cao P, Klonis N, Zaloumis S, Dogovski C, Xie SC, Saralamba S, White LJ, Fowkes FJI, Tilley L, Simpson JA, McCaw JM.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00618-17. doi: 10.1128/AAC.00618-17. Print 2017 Dec.

36.

Declining Malaria Transmission Differentially Impacts the Maintenance of Humoral Immunity to Plasmodium falciparum in Children.

Mugyenyi CK, Elliott SR, Yap XZ, Feng G, Boeuf P, Fegan G, Osier FFH, Fowkes FJI, Avril M, Williams TN, Marsh K, Beeson JG.

J Infect Dis. 2017 Oct 17;216(7):887-898. doi: 10.1093/infdis/jix370.

37.

Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis.

Moore KA, Simpson JA, Scoullar MJL, McGready R, Fowkes FJI.

Lancet Glob Health. 2017 Nov;5(11):e1101-e1112. doi: 10.1016/S2214-109X(17)30340-6. Epub 2017 Sep 26. Review.

38.

Declining Transmission and Immunity to Malaria and Emerging Artemisinin Resistance in Thailand: A Longitudinal Study.

Ataíde R, Powell R, Moore K, McLean A, Phyo AP, Nair S, White M, Anderson TJ, Beeson JG, Simpson JA, Nosten F, Fowkes FJI.

J Infect Dis. 2017 Sep 15;216(6):723-731. doi: 10.1093/infdis/jix371.

39.

Maximizing the impact of malaria funding through allocative efficiency: using the right interventions in the right locations.

Scott N, Hussain SA, Martin-Hughes R, Fowkes FJI, Kerr CC, Pearson R, Kedziora DJ, Killedar M, Stuart RM, Wilson DP.

Malar J. 2017 Sep 12;16(1):368. doi: 10.1186/s12936-017-2019-1.

40.
41.

Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.

Chan JA, Stanisic DI, Duffy MF, Robinson LJ, Lin E, Kazura JW, King CL, Siba PM, Fowkes FJ, Mueller I, Beeson JG.

Eur J Immunol. 2017 Dec;47(12):2124-2136. doi: 10.1002/eji.201747032. Epub 2017 Sep 13.

42.

Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar.

Draper BL, Fowkes FJI, Oo ZM, Thein ZW, Aung PP, Veronese V, Ryan C, Thant M, Hughes C, Stoové M.

J Int AIDS Soc. 2017 Jul 26;20(1):21885. doi: 10.7448/IAS.20.1.21885. Erratum in: J Int AIDS Soc. 2017;20(1):22284.

43.

Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission.

Moore KA, Simpson JA, Wiladphaingern J, Min AM, Pimanpanarak M, Paw MK, Raksuansak J, Pukrittayakamee S, Fowkes FJI, White NJ, Nosten F, McGready R.

BMC Med. 2017 Jun 21;15(1):117. doi: 10.1186/s12916-017-0877-6.

44.

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.

Hess CN, Norgren L, Ansel GM, Capell WH, Fletcher JP, Fowkes FGR, Gottsäter A, Hitos K, Jaff MR, Nordanstig J, Hiatt WR.

Circulation. 2017 Jun 20;135(25):2534-2555. doi: 10.1161/CIRCULATIONAHA.117.024469. Review. Erratum in: Circulation. 2017 Nov 7;136(19):e347.

PMID:
28630267
45.

Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum.

McLean ARD, Boel M, McGready R, Ataide R, Drew D, Tsuboi T, Beeson JG, Nosten F, Simpson JA, Fowkes FJI.

Am J Trop Med Hyg. 2017 May;96(5):1197-1204. doi: 10.4269/ajtmh.16-0690.

46.

2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary.

Writing Committee Members, Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME; ACC/AHA Task Force Members, Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J, Joglar J, Pressler SJ, Wijeysundera DN.

Vasc Med. 2017 Jun;22(3):NP1-NP43. doi: 10.1177/1358863X17701592. Review. No abstract available.

PMID:
28494710
47.

Mediation of the effect of malaria in pregnancy on stillbirth and neonatal death in an area of low transmission: observational data analysis.

Moore KA, Fowkes FJI, Wiladphaingern J, Wai NS, Paw MK, Pimanpanarak M, Carrara VI, Raksuansak J, Simpson JA, White NJ, Nosten F, McGready R.

BMC Med. 2017 May 10;15(1):98. doi: 10.1186/s12916-017-0863-z.

48.

Immunity as a predictor of anti-malarial treatment failure: a systematic review.

O'Flaherty K, Maguire J, Simpson JA, Fowkes FJI.

Malar J. 2017 Apr 20;16(1):158. doi: 10.1186/s12936-017-1815-y. Review.

49.

Ticagrelor versus Clopidogrel in Peripheral Artery Disease.

Patel MR, Fowkes FG, Hiatt WR.

N Engl J Med. 2017 Apr 13;376(15):1488-9. doi: 10.1056/NEJMc1701197. No abstract available.

PMID:
28402763
50.

Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort.

Ataide R, Ashley EA, Powell R, Chan JA, Malloy MJ, O'Flaherty K, Takashima E, Langer C, Tsuboi T, Dondorp AM, Day NP, Dhorda M, Fairhurst RM, Lim P, Amaratunga C, Pukrittayakamee S, Hien TT, Htut Y, Mayxay M, Faiz MA, Beeson JG, Nosten F, Simpson JA, White NJ, Fowkes FJ.

Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3515-3520. doi: 10.1073/pnas.1615875114. Epub 2017 Mar 13.

Supplemental Content

Loading ...
Support Center